Michael Zile to Growth Differentiation Factor 15
This is a "connection" page, showing publications Michael Zile has written about Growth Differentiation Factor 15.
Connection Strength
0.151
-
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2018 12; 20(12):1701-1709.
Score: 0.151